BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $6.69 billion. The enterprise value is $7.93 billion.

Market Cap	6.69B
Enterprise Value	7.93B

Important Dates

The last earnings date was Tuesday, April 29, 2025, after market close.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

BBIO has 189.88 million shares outstanding. The number of shares has increased by 11.59% in one year.

Current Share Class	189.88M
Shares Outstanding	189.88M
Shares Change (YoY)	+11.59%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	4.84%
Owned by Institutions (%)	69.09%
Float	139.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	51.68
Forward PS	24.20
PB Ratio	-4.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	62.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.57

Current Ratio	4.57
Quick Ratio	4.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-48.27%
Return on Invested Capital (ROIC)	-91.66%
Return on Capital Employed (ROCE)	-91.62%
Revenue Per Employee	$174,541
Profits Per Employee	-$915,025
Employee Count	730
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

In the past 12 months, BBIO has paid $1.15 million in taxes.

Income Tax	1.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.41% in the last 52 weeks. The beta is 1.15, so BBIO's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+25.41%
50-Day Moving Average	34.37
200-Day Moving Average	29.49
Relative Strength Index (RSI)	47.02
Average Volume (20 Days)	3,219,731

Short Selling Information

The latest short interest is 22.31 million, so 11.75% of the outstanding shares have been sold short.

Short Interest	22.31M
Short Previous Month	21.71M
Short % of Shares Out	11.75%
Short % of Float	16.01%
Short Ratio (days to cover)	8.09

Income Statement

In the last 12 months, BBIO had revenue of $127.42 million and -$667.97 million in losses. Loss per share was -$3.54.

Revenue	127.42M
Gross Profit	121.50M
Operating Income	-668.41M
Pretax Income	-453.82M
Net Income	-667.97M
EBITDA	-662.65M
EBIT	-668.41M
Loss Per Share	-$3.54

Balance Sheet

The company has $540.60 million in cash and $1.86 billion in debt, giving a net cash position of -$1.32 billion or -$6.94 per share.

Cash & Cash Equivalents	540.60M
Total Debt	1.86B
Net Cash	-1.32B
Net Cash Per Share	-$6.94
Equity (Book Value)	-1.64B
Book Value Per Share	-8.68
Working Capital	543.07M

Cash Flow

In the last 12 months, operating cash flow was -$500.42 million and capital expenditures -$238,000, giving a free cash flow of -$500.66 million.

Operating Cash Flow	-500.42M
Capital Expenditures	-238,000
Free Cash Flow	-500.66M
FCF Per Share	-$2.64

Margins

Gross Margin	95.35%
Operating Margin	-524.60%
Pretax Margin	-530.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.59%
Shareholder Yield	-11.59%
Earnings Yield	-10.09%
FCF Yield	-7.57%

Analyst Forecast

The average price target for BBIO is $57.09, which is 62.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$57.09
Price Target Difference	62.14%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	59.46%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BBIO has an Altman Z-Score of -5.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.54
Piotroski F-Score	1